EichorEICHOR
Condition: Stage 3 Amd Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Stage 3 Amd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Lutein by Scleral Iontophoresis in AMD
Phase N/A · 1 location(s) · Federico II University · NCT06925893Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · 79 location(s) · Adverum Biotechnologies, Inc. · NCT07482176A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · 56 location(s) · Kodiak Sciences Inc · NCT06990399Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · 94 location(s) · 4D Molecular Therapeutics · NCT07064759Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to E
Phase 3 · 36 location(s) · King's College Hospital NHS Trust · NCT04663750National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and
Phase N/A · 2 location(s) · National Eye Institute (NEI) · NCT06491615Study of ALK-001 on the Progression of Stargardt Disease
Phase 3 · 5 location(s) · Alkeus Pharmaceuticals, Inc. · NCT07419334A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · 97 location(s) · EyeBiotech Ltd. · NCT07440225Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Wi
Phase 3 · 1 location(s) · SANGMYUNG innovation · NCT07695207A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Phase 2/Phase 3 · 71 location(s) · EyeBiotech Ltd. · NCT07496567A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult
Phase 3 · 223 location(s) · Regeneron Pharmaceuticals · NCT06541704A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · 56 location(s) · Kodiak Sciences Inc · NCT06996080
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.